Skip to content

Clinical trials

Thrombotic Microangiopathies trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombotic Microangiopathies Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20201
20222
20231
20244
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Completed3
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals3
The First Affiliated Hospital of Soochow University3
Alexion Pharmaceuticals, Inc.1
First Affiliated Hospital of Zhejiang University1
Institute of Hematology & Blood Diseases Hospital, China1
Peking University People's Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombotic Microangiopathies10
Atypical Hemolytic Uremic Syndrome3
Disseminated Intravascular Coagulation1
Glomerulonephritis, Membranoproliferative1
Hematologic Diseases1
Hemophilia A1
Hemophilia B1
Hemostatic Disorders1
Pulmonary Embolism1
Purpura, Thrombocytopenic, Idiopathic1

Trials

Showing 26 to 10 of 10. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.